Skip to main content
Equibles
DXCM logo

DXCM · Dexcom Inc · Metrics

Track DXCM — free

Use DXCM with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$85.37 -2.53 (-2.88%)
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$33.17B
Shares
377.36M

DXCM metrics

81 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$87.90
Market cap
$33.17B

Price action

20 metrics
Price change (1W)
-3.2%
Price change (30D)
+0.3%
Price change (3M)
+20.6%
Price change (6M)
+29.1%
Price change (YTD)
+32.4%
Price change (1Y)
+8.8%
Trailing year
Price change (5Y)
—
52-week high
$92.34
52-week low
$54.84
Change from 52-week high
-4.8%
Change from 52-week low
+60.3%
Annualized volatility
41.1%
Annualized volatility (3M)
—
Beta
0.7
RSI (14D)
52.9
Price vs SMA 50
+8.2%
Price vs SMA 200
+24.0%
Avg volume (3M)
4.80M
Relative volume
0.5
Average dollar volume
$380.23M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
377.36M

Valuation

12 metrics
P / E (TTM)
34.9
Trailing earnings · reciprocal yield 2.9%
PEG ratio
0.8
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.7×
reciprocal yield 15.0%
P / book
12.7
reciprocal yield 7.9%
FCF yield
4.2%
TTM · current market cap
Buyback yield
3.3%
P / FCF
23.6
reciprocal yield 4.2%
P / operating cash flow
19.0
reciprocal yield 5.3%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
57.6×
reciprocal yield 1.7%
P / E historical average (5Y)
96.0×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
3.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
62.5%
Operating margin
22.9%
Trailing 12 months
Net margin
20.1%
Gross profit (TTM)
$3.10B
Operating profit (TTM)
$1.14B
Net income (TTM)
$999.70M
Trailing 12 months
Diluted EPS (TTM)
$2.52
FCF margin
28.3%
Effective tax rate
21.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.25

Growth

11 metrics
Revenue growth YoY
+13.1%
Year over year
Net income growth YoY
+38.5%
Revenue (TTM)
$4.97B
Trailing 12 months
EPS growth YoY
+42.2%
Shares change YoY
-4.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+17.0%
Revenue CAGR (5Y)
+19.3%
EPS CAGR (3Y)
+36.6%
EPS CAGR (5Y)
+9.5%
FCF CAGR (3Y)
+52.3%
FCF CAGR (5Y)
+31.2%

Quality

14 metrics
Return on equity
38.1%
Return on assets
15.5%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$1.40B
Free cash flow (TTM)
$1.41B
Quick ratio
1.4
Interest coverage
75.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.10B
Total assets
$6.46B
Total debt
$2.90M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.75B
Capital expenditures (TTM)
$343.70M
R&D (TTM)
$604.00M
SG&A (TTM)
$1.36B
Stock compensation (TTM)
$162.40M
R&D / revenue
12.2%
Stock compensation / revenue
3.3%

Ownership (13F)

3 metrics
13F filers
977
13F filer change QoQ
+10
Institutional ownership
104.7%

Short interest

3 metrics
Short interest
4.4%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$7.73M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1093557 CUSIP 252131107 13F (30d) 489 filings 486 filers Visit website Investor relations